82102946/National Natural Science Foundation of China[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2022	1
2024	2

Page 1

Histone H3K9 Lactylation Confers Temozolomide Resistance in Glioblastoma via LUC7L2-Mediated MLH1 Intron Retention.

Yue Q, Wang Z, Shen Y, Lan Y, Zhong X, Luo X, Yang T, Zhang M, Zuo B, Zeng T, Lu J, Wang Y, Liu B, Guo H. Yue Q, et al. Adv Sci (Weinh). 2024 May;11(19):e2309290. doi: 10.1002/advs.202309290. Epub 2024 Mar 13. Adv Sci (Weinh). 2024. PMID: 38477507 Free PMC article.

ALKBH5 promotes PD-L1-mediated immune escape through m6A modification of ZDHHC3 in glioma.

Tang W, Xu N, Zhou J, He Z, Lenahan C, Wang C, Ji H, Liu B, Zou Y, Zeng H, Guo H. Tang W, et al. Cell Death Discov. 2022 Dec 24;8(1):497. doi: 10.1038/s41420-022-01286-w. Cell Death Discov. 2022. PMID: 36566230 Free PMC article.

IL-18, a therapeutic target for immunotherapy boosting, promotes temozolomide chemoresistance via the PI3K/AKT pathway in glioma.

Ji H, Lan Y, Xing P, Wang Z, Zhong X, Tang W, Wei Q, Chen H, Liu B, Guo H. Ji H, et al. J Transl Med. 2024 Oct 21;22(1):951. doi: 10.1186/s12967-024-05755-x. J Transl Med. 2024. PMID: 39434175 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year